A detailed history of Nuveen Asset Management, LLC transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 40,827 shares of AKYA stock, worth $116,765. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,827
Previous 40,827 -0.0%
Holding current value
$116,765
Previous $191,000 50.26%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$3.13 - $5.13 $35,847 - $58,753
11,453 Added 38.99%
40,827 $199,000
Q1 2023

May 15, 2023

SELL
$7.6 - $12.68 $1,869 - $3,119
-246 Reduced 0.83%
29,374 $240,000
Q2 2022

Aug 15, 2022

BUY
$8.38 - $12.85 $83,749 - $128,422
9,994 Added 50.92%
29,620 $381,000
Q3 2021

Nov 12, 2021

BUY
$13.04 - $21.0 $98,126 - $158,025
7,525 Added 62.18%
19,626 $412,000
Q2 2021

Aug 16, 2021

BUY
$17.89 - $26.05 $216,486 - $315,231
12,101 New
12,101 $234,000

Others Institutions Holding AKYA

About Akoya Biosciences, Inc.


  • Ticker AKYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,892,300
  • Market Cap $108M
  • Description
  • Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...
More about AKYA
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.